Literature DB >> 14749719

p41-Arc subunit of human Arp2/3 complex is a p21-activated kinase-1-interacting substrate.

Ratna K Vadlamudi1, Feng Li, Christopher J Barnes, Rozita Bagheri-Yarmand, Rakesh Kumar.   

Abstract

The formation of new branched actin filament networks at the cell cortex of migrating cells is choreographed by the actin-related protein (Arp) 2/3 complex. Despite the fundamental role of the Arp2/3 complex in actin nucleation and branching, upstream signals that control the functions of p41-Arc, a putative regulatory component of the mammalian Arp2/3 complex, remain unidentified. Here we show that p41-Arc interacts with p21-activated kinase 1 (Pak1) both in vitro and in vivo. Pak1 phosphorylation of p41-Arc regulates its localization with the Arp2/3 complex in the cortical nucleation regions of cells. Pak1 phosphorylates p41-Arc on threonine 21 in the first WD repeat, and its mutation has functional implications in vivo. Threonine 21 phosphorylation by Pak1 is required for both constitutive and growth-factor-induced cell motility. Pak1 regulation of p41-Arc activation status represents a novel mechanism by which signalling pathways may influence the functions of the Arp2/3 complex, leading to motility in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749719      PMCID: PMC1298990          DOI: 10.1038/sj.embor.7400079

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  17 in total

Review 1.  The world according to Arp: regulation of actin nucleation by the Arp2/3 complex.

Authors:  M D Welch
Journal:  Trends Cell Biol       Date:  1999-11       Impact factor: 20.808

Review 2.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

3.  Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics.

Authors:  D C Edwards; L C Sanders; G M Bokoch; G N Gill
Journal:  Nat Cell Biol       Date:  1999-09       Impact factor: 28.824

Review 4.  Structure and function of the Arp2/3 complex.

Authors:  R D Mullins; T D Pollard
Journal:  Curr Opin Struct Biol       Date:  1999-04       Impact factor: 6.809

5.  A rapid in vitro assay for quantitating the invasive potential of tumor cells.

Authors:  A Albini; Y Iwamoto; H K Kleinman; G R Martin; S A Aaronson; J M Kozlowski; R N McEwan
Journal:  Cancer Res       Date:  1987-06-15       Impact factor: 12.701

6.  The interaction of Arp2/3 complex with actin: nucleation, high affinity pointed end capping, and formation of branching networks of filaments.

Authors:  R D Mullins; J A Heuser; T D Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  Crystal structure of Arp2/3 complex.

Authors:  R C Robinson; K Turbedsky; D A Kaiser; J B Marchand; H N Higgs; S Choe; T D Pollard
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

8.  Genetic dissection of the budding yeast Arp2/3 complex: a comparison of the in vivo and structural roles of individual subunits.

Authors:  D C Winter; E Y Choe; R Li
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

9.  The human Arp2/3 complex is composed of evolutionarily conserved subunits and is localized to cellular regions of dynamic actin filament assembly.

Authors:  M D Welch; A H DePace; S Verma; A Iwamatsu; T J Mitchison
Journal:  J Cell Biol       Date:  1997-07-28       Impact factor: 10.539

10.  Temporal and spatial distribution of activated Pak1 in fibroblasts.

Authors:  M A Sells; A Pfaff; J Chernoff
Journal:  J Cell Biol       Date:  2000-12-25       Impact factor: 10.539

View more
  68 in total

1.  Accelerators, Brakes, and Gears of Actin Dynamics in Dendritic Spines.

Authors:  Crystal G Pontrello; Iryna M Ethell
Journal:  Open Neurosci J       Date:  2009-01-01

Review 2.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

Review 3.  Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations.

Authors:  Jeyanthy Eswaran; Da-Qiang Li; Anil Shah; Rakesh Kumar
Journal:  Clin Cancer Res       Date:  2012-05-17       Impact factor: 12.531

Review 4.  Small Rho GTPases in the control of cell shape and mobility.

Authors:  Arun Murali; Krishnaraj Rajalingam
Journal:  Cell Mol Life Sci       Date:  2013-11-26       Impact factor: 9.261

5.  Dissecting activation of the PAK1 kinase at protrusions in living cells.

Authors:  Maria Carla Parrini; Jacques Camonis; Michiyuki Matsuda; Jean de Gunzburg
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

6.  RhoJ modulates melanoma invasion by altering actin cytoskeletal dynamics.

Authors:  Hsiang Ho; Amelia Soto Hopkin; Rubina Kapadia; Priya Vasudeva; Jonathan Schilling; Anand K Ganesan
Journal:  Pigment Cell Melanoma Res       Date:  2013-01-07       Impact factor: 4.693

7.  Phosphorylation of actin-related protein 2 (Arp2) is required for normal development and cAMP chemotaxis in Dictyostelium.

Authors:  Chang-Hoon Choi; Peter A Thomason; Mehreen Zaki; Robert H Insall; Diane L Barber
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

8.  A p21-activated kinase (PAK1) signaling cascade coordinately regulates F-actin remodeling and insulin granule exocytosis in pancreatic β cells.

Authors:  Michael A Kalwat; Stephanie M Yoder; Zhanxiang Wang; Debbie C Thurmond
Journal:  Biochem Pharmacol       Date:  2012-12-16       Impact factor: 5.858

9.  Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora A.

Authors:  Poonam R Molli; Da-Qiang Li; Rozita Bagheri-Yarmand; Suresh B Pakala; Hiroshi Katayama; Subrata Sen; Jyoti Iyer; Jonathan Chernoff; Ming-Ying Tsai; Sujit S Nair; Rakesh Kumar
Journal:  J Cell Biol       Date:  2010-07-05       Impact factor: 10.539

Review 10.  PAK signaling in oncogenesis.

Authors:  P R Molli; D Q Li; B W Murray; S K Rayala; R Kumar
Journal:  Oncogene       Date:  2009-05-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.